U.S. flag

An official website of the United States government

NM_000019.4(ACAT1):c.622C>T (p.Arg208Ter) AND Deficiency of acetyl-CoA acetyltransferase

Germline classification:
Pathogenic (6 submissions)
Last evaluated:
Oct 6, 2025
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000689417.17

Allele description [Variation Report for NM_000019.4(ACAT1):c.622C>T (p.Arg208Ter)]

NM_000019.4(ACAT1):c.622C>T (p.Arg208Ter)

Gene:
ACAT1:acetyl-CoA acetyltransferase 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11q22.3
Genomic location:
Preferred name:
NM_000019.4(ACAT1):c.622C>T (p.Arg208Ter)
HGVS:
  • NC_000011.10:g.108140107C>T
  • NG_009888.2:g.28403C>T
  • NM_000019.4:c.622C>TMANE SELECT
  • NP_000010.1:p.Arg208Ter
  • LRG_1400t1:c.622C>T
  • LRG_1400:g.28403C>T
  • LRG_1400p1:p.Arg208Ter
  • NC_000011.9:g.108010834C>T
  • NG_009888.1:g.23577C>T
  • NM_000019.3:c.622C>T
Protein change:
R208*
Links:
dbSNP: rs532190594
Molecular consequence:
  • NM_000019.4:c.622C>T - nonsense - [Sequence Ontology: SO:0001587]
Observations:
1

Condition(s)

Name:
Deficiency of acetyl-CoA acetyltransferase
Synonyms:
3-KETOTHIOLASE DEFICIENCY; 3-OXOTHIOLASE DEFICIENCY; MITOCHONDRIAL ACETOACETYL-CoA THIOLASE DEFICIENCY; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0008760; MedGen: C1536500; Orphanet: 134; OMIM: 203750

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000817065Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Oct 6, 2025)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

SCV000966070Department of Pediatrics, Gifu University
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(May 5, 2019)
germlineresearch

PubMed (2)
[See all records that cite these PMIDs]

SCV001461795Natera, Inc.
criteria provided, single submitter

(Natera Variant Classification Schema (03/2026))
Pathogenic
(Sep 11, 2025)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link,

SCV002041661Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Pathogenic
(Nov 21, 2021)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Citation Link,

SCV004210497Baylor Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Mar 25, 2024)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

SCV004800856Neonatal Disease Screening Center, Medical Genetics Center, Huaihua City Maternal and Child Health Care Hospital
no assertion criteria provided

(ACMG Guidelines, 2015)
Pathogenicgermlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing
not providedgermlineyes3128not providednot providedyesresearch
Miaogermlineyes1not providednot provided1not providedclinical testing

Citations

PubMed

Molecular basis of beta-ketothiolase deficiency: mutations and polymorphisms in the human mitochondrial acetoacetyl-coenzyme A thiolase gene.

Fukao T, Yamaguchi S, Orii T, Hashimoto T.

Hum Mutat. 1995;5(2):113-20. Review.

PubMed [citation]
PMID:
7749408

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group, Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9..

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818
See all PubMed Citations (7)
PMC

bad uid value: PMC4544753: NCBI C++ Exception: Error: CORELIB(CStringException::eConvert) "/pubmed_gen/rbuild/version/20260106/cidx/2.10.3/src/corelib/ncbistr.cpp", line 973: ncbi::NStr::StringToUInt8() --- Cannot convert string 'PMC4544753' to Uint8 (m_Pos = 0)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000817065.8

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

This sequence change creates a premature translational stop signal (p.Arg208*) in the ACAT1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ACAT1 are known to be pathogenic (PMID: 7749408). This variant is present in population databases (rs532190594, gnomAD 0.01%). This premature translational stop signal has been observed in individuals with acetoacetyl-CoA-thiolase deficiency (PMID: 20156697, 28220263). It is commonly reported in individuals of Vietnamese ancestry (PMID: 20156697, 28220263). ClinVar contains an entry for this variant (Variation ID: 376832). For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Department of Pediatrics, Gifu University, SCV000966070.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided31not providedyesresearch PubMed (2)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided31not provided28not provided

From Natera, Inc., SCV001461795.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

The c.622C>T variant in ACAT1 is a nonsense variant predicted to introduce a stop codon at amino acid 208. This variant is expected to result in nonsense mediated decay, truncation, or a dysfunctional protein product. This variant is rare in the general population with a frequency below the threshold expected for the associated phenotype(s). This variant has been observed in one or more individuals affected with the associated recessive disease, as either homozygous or compound heterozygous with a second variant (PMID: 28220263). Given the available evidence, this variant is classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV002041661.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

Variant summary: ACAT1 c.622C>T (p.Arg208X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 1.2e-05 in 251186 control chromosomes. c.622C>T has been reported in the literature as a homozygous and compound heterozygous genotype in multiple individuals affected with Mitochondrial Acetoacetyl-CoA Thiolase Deficiency (example, Nguyen_2017, Fukao_2010, Lin_2021). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Four clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and all submitters classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Baylor Genetics, SCV004210497.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

From Neonatal Disease Screening Center, Medical Genetics Center, Huaihua City Maternal and Child Health Care Hospital, SCV004800856.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1Miao1not providednot providedclinical testingnot provided

Description

PS3+PM2_P+PM3_S+PP4

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyes1not providednot provided1not providednot providednot provided

Last Updated: Apr 12, 2026

Modify your search Search (all fields optional) Clear all
Advanced Search